199 related articles for article (PubMed ID: 17305016)
1. NCI's cancer therapy evaluation program: a commitment to treatment trials.
Abrams JS; Murgo A; Christian MC
Cancer Treat Res; 2007; 132():31-50. PubMed ID: 17305016
[No Abstract] [Full Text] [Related]
2. Redesigning NCI's clinical trials system: integration is the goal.
McNeil C
J Natl Cancer Inst; 2005 Jan; 97(2):92-3. PubMed ID: 15657338
[No Abstract] [Full Text] [Related]
3. Investigational trials of anticancer drugs: establishing safeguards for experimentation.
Chabner BA; Wittes R; Hoth D; Hubbard S
Public Health Rep; 1984; 99(4):355-60. PubMed ID: 6431482
[TBL] [Abstract][Full Text] [Related]
4. The NCI's Clinical Trials Working Group: performing a task worthy of our attention.
O'donnell JF
J Cancer Educ; 2005; 20(2):64. PubMed ID: 16083365
[No Abstract] [Full Text] [Related]
5. NCI announces plan to overhaul clinical-trials system.
Miller JL
Am J Health Syst Pharm; 2000 Jul; 57(13):1202. PubMed ID: 10902058
[No Abstract] [Full Text] [Related]
6. The role of user input in shaping online information from the National Cancer Institute.
Grama LM; Beckwith M; Bittinger W; Blais D; Lollar C; Middleswarth A; Noone M; Price D; Quint-Kasner S; Shields V; Wright LW
J Med Internet Res; 2005 Jul; 7(3):e25. PubMed ID: 15998616
[TBL] [Abstract][Full Text] [Related]
7. Role of clinical trials informatics in the NCI's cancer informatics infrastructure.
Silva J; Wittes R
Proc AMIA Symp; 1999; ():950-4. PubMed ID: 10566501
[TBL] [Abstract][Full Text] [Related]
8. Diet and chemoprevention in NCI's research strategy to achieve national cancer control objectives.
Greenwald P; Sondik E; Lynch BS
Annu Rev Public Health; 1986; 7():267-91. PubMed ID: 3013230
[No Abstract] [Full Text] [Related]
9. NCI's clinical trial system: efficiencies grow, debate goes on.
Nicholas J
J Natl Cancer Inst; 2010 Dec; 102(23):1750-1, 1755. PubMed ID: 21088280
[No Abstract] [Full Text] [Related]
10. OTA peers into cancer therapy fog.
Marshall E
Science; 1990 Sep; 249(4975):1369. PubMed ID: 2402632
[No Abstract] [Full Text] [Related]
11. Q&A: Ned Sharpless on His Vision for NCI.
Cancer Discov; 2018 Jun; 8(6):669. PubMed ID: 29728362
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
[TBL] [Abstract][Full Text] [Related]
13. NCI-MATCH launch highlights new trial design in precision-medicine era.
McNeil C
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
[No Abstract] [Full Text] [Related]
14. Lessons learned from recent cardiovascular clinical trials: Part II.
DeMets DL; Califf RM
Circulation; 2002 Aug; 106(7):880-6. PubMed ID: 12176964
[No Abstract] [Full Text] [Related]
15. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
16. NCI's breast cancer clinical alert: rationale and results.
DeVita VT; Hubbard SM
Resid Staff Physician; 1989 Jul; 35(8):49-55. PubMed ID: 10303742
[TBL] [Abstract][Full Text] [Related]
17. Cancer institute to tighten control of trials.
Gavaghan H
Nature; 1994 Apr; 368(6473):679. PubMed ID: 8152474
[No Abstract] [Full Text] [Related]
18. Representation of older patients in cancer treatment trials.
Trimble EL; Carter CL; Cain D; Freidlin B; Ungerleider RS; Friedman MA
Cancer; 1994 Oct; 74(7 Suppl):2208-14. PubMed ID: 8087794
[TBL] [Abstract][Full Text] [Related]
19. Jeffrey White directs NCI's new Office of Alternative Medicine. Interview by Nancy Nelson.
White J
J Natl Cancer Inst; 1999 Feb; 91(4):313-4. PubMed ID: 10050863
[No Abstract] [Full Text] [Related]
20. Clinical research programs in vision: The National Eye Institute perspective.
Goldberg IA
Am J Optom Physiol Opt; 1981 Apr; 58(4):270-6. PubMed ID: 7282850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
